Ophthalmology Times - Ophthalmology news, articles, and events
WEBBy Alice Epitropoulos, MD. September 15th 2024. Common glaucoma treatments may worsen ocular surface disease and meibomian gland dysfunction, leading to discomfort, redness, and even poor treatment compliance. Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner …
Physicians sort out pros and cons of several new IOLs on the market
WEBNov 12, 2021 · The new IOL in the EDoF category is the AcrySof IQ Vivity (Alcon). The Vivity uses wavefront-shaping technology on its anterior surface that elongates the depth of focus, giving about a 1.5 D range of vision. Because it is a nondiffractive lens, risks of glare and halos are minimized and quality of vision is better than with a multifocal IOL.
Blog: Artificial tear therapy for dry eye disease not quite as simple ...
WEBJul 18, 2022 · First choices often include heated moisture masks, humidifiers, and eyelid cleansing wipes, while prescription therapies range from immunosuppressants, steroids, and specialized contact lenses to in-office procedures such as intense pulsed light, microblepharoexfoliation, and thermal evacuation. But across …
FDA approves eye drops for treatment of presbyopia
WEBOct 30, 2021 · Allergan developed VUITY, which it noted is the first and only FDA-approved eye drop to treat presbyopia. Allergan, an AbbVie company, announced FDA approval of pilocarpine HCl ophthalmic solution 1.25% (VUITY) for the treatment of presbyopia, commonly known as age-related blurry near vision, in adults. According to the company, pilocarpine HCl ...
Dispelling myths about refractive lens exchange - Ophthalmology …
WEBSep 7, 2020 · Ninety-nine percent of the responders considered themselves refractive surgeons and 34% had undergone a laser vision correction themselves. Almost 50% of those who underwent laser vision correction were in their 30s, 30% in their 40s, and 22% in their 20s at the time of surgery. Of the survey responders, 8.5% reported having undergone a …
Breaking down the dorzolamide shortage - Ophthalmology Times
WEBAug 9, 2019 · Essentially, brimonidine 0.1% (Alphagan P, Allergan) is often a reasonable substitution for dorzolamide, while brimonidine-timolol (Combigan, Allergan) is an ideal substitution for dorzolamide-timolol shortages, assuming no brimonidine allergy. Certainly, the dorzolamide shortage has helped us view branded pharmaceutical companies in …
New IOL design gives premium results from non-premium lens
WEBJun 14, 2018 · New IOL design gives premium results from non-premium lens. June 14, 2018. By Fred Gebhart. Article. The latest iteration of a certain IOL family (enVista, Bausch + Lomb) is receiving positive feedback from early surgical users. For starters, the MX60E opens in about 20 seconds compared with 2.5 minutes for …
Ophthalmologists: Castor oil shouldn’t be rubbed in the eyes, no …
WEBAug 8, 2023 · Ophthalmologists are issuing a warning not to use castor oil as a way to treat vision problems amid claims circulating on TikTok. In its heyday, castor oil was considered a jack-of-all-trades home remedy, used as a laxative, a moisturizer and even as a chest rub to ease lung congestion. Now, it is making a comeback as some influencers on TikTok ...
Focusing on xerophthalmia, vitamin A deficiency - Ophthalmology …
WEBJul 5, 2019 · Xerophthalmia, a form of dry eye that results from vitamin A deficiency, was recognized medically as far back as 1520 BC. A treatment was devised that involved cooking beef liver, and then squeezing the “juice” of the liver on the affected eyes, according to Alfred Sommer, MD, MHS In 1977, George Wald …
Cosmetic eyeliner tattoo as risk factor for ocular surface disease
WEBJan 1, 2018 · Cosmetic eyeliner tattoo as risk factor for ocular surface disease. January 1, 2018. Article. Ophthalmology Times is pleased to announce Igor I. Bussel, MD, MS, MHA, and Deepinder K. Dhaliwal, MD (faculty sponsor), of the Department of Ophthalmology, University of Pittsburgh/UPMC Eye Center, Pittsburgh, as …